The pooled prevalence of chronic painful neuropathy is 41.22 percent among individuals with chemotherapy-induced peripheral ...

NeuFit is revolutionizing neurological rehabilitation with its innovative approach that integrates advanced diagnostics and ...

The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...

A lymphoma specialist who survived her own tumor surgery helps patients navigate the daunting decisions to be made.

Despite its seemingly harmless name, vitamin B12 deficiency is notoriously harmless and sneaky. The nutrient is essential for ...

Vistagen , a clinical-stage biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders, today announced ...

DELRAY BEACH, FL / ACCESS Newswire / February 4, 2025 / Adolore BioTherapeutics ("Adolore" or the "Company"), is developing ...

The PATHWAY HER2 (4B5) test is now FDA-approved to assess HER2-ultralow status in metastatic breast cancer, expanding its ...

DELRAY BEACH, FL / ACCESS Newswire / February 4, 2025 / Adolore BioTherapeutics ("Adolore" or the "Company"), is developing intracellularly-delivered neuromodulators that naturally reduce neuronal exc ...

It warns: "You need to tell DVLA about some medical conditions as they can affect your driving. You can be fined up to £1,000 ...